Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
44.22
+0.70 (1.61%)
Mar 28, 2024, 9:38 AM EDT - Market open
Amphastar Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 144.53 | 156.33 | 126.59 | 94.51 | 75.55 | 88.2 | 69.75 | 73.74 | 66.07 | 69.32 | Upgrade
|
Short-Term Investments | 114.71 | 21.86 | 12.52 | 15.18 | 13.97 | 5.12 | 2.64 | 0.53 | 1.29 | 0 | Upgrade
|
Cash & Cash Equivalents | 259.24 | 178.2 | 139.11 | 109.68 | 89.52 | 93.32 | 72.38 | 74.27 | 67.36 | 69.32 | Upgrade
|
Cash Growth | 45.48% | 28.10% | 26.83% | 22.53% | -4.08% | 28.93% | -2.54% | 10.26% | -2.83% | 26.24% | Upgrade
|
Receivables | 114.94 | 88.8 | 78.8 | 66.01 | 45.38 | 52.16 | 36 | 26.78 | 33.23 | 22.85 | Upgrade
|
Inventory | 105.83 | 103.58 | 92.81 | 96.83 | 110.5 | 69.32 | 63.61 | 79.75 | 70.67 | 82.33 | Upgrade
|
Other Current Assets | 9.58 | 7.73 | 7.4 | 7.16 | 9.85 | 5.53 | 15.79 | 3.29 | 4.68 | 23.49 | Upgrade
|
Total Current Assets | 489.6 | 378.32 | 318.12 | 279.68 | 255.24 | 220.34 | 187.78 | 184.1 | 175.93 | 198 | Upgrade
|
Property, Plant & Equipment | 315.64 | 264.57 | 271.49 | 280.71 | 253.55 | 210.42 | 180.55 | 152.94 | 142.16 | 138.29 | Upgrade
|
Long-Term Investments | 15.21 | 2.41 | 3.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Goodwill and Intangibles | 613.3 | 37.3 | 38.87 | 40.62 | 41.15 | 42.27 | 45.14 | 50.31 | 39.9 | 42.57 | Upgrade
|
Other Long-Term Assets | 79.16 | 59.38 | 39.06 | 30.23 | 37.03 | 40.54 | 37.61 | 40.39 | 32.14 | 10.52 | Upgrade
|
Total Long-Term Assets | 1,023 | 363.67 | 353.41 | 351.55 | 331.73 | 293.22 | 263.29 | 243.64 | 214.2 | 191.37 | Upgrade
|
Total Assets | 1,513 | 741.99 | 671.53 | 631.24 | 586.97 | 513.56 | 451.07 | 427.74 | 390.14 | 389.37 | Upgrade
|
Accounts Payable | 93.37 | 84.24 | 89.55 | 95.5 | 77.05 | 87.42 | 57.56 | 47.55 | 13.87 | 10.16 | Upgrade
|
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.98 | 16 | Upgrade
|
Current Debt | 4.34 | 6.05 | 5.18 | 15.62 | 10.92 | 18.23 | 6.31 | 5.37 | 10.93 | 7.59 | Upgrade
|
Other Current Liabilities | 127.7 | 4.57 | 9.08 | 1.08 | 2.04 | 1.19 | 3.33 | 7.71 | 33.17 | 28.85 | Upgrade
|
Total Current Liabilities | 225.41 | 94.86 | 103.81 | 112.2 | 90.01 | 106.83 | 67.19 | 60.62 | 59.96 | 62.6 | Upgrade
|
Long-Term Debt | 619.3 | 96.53 | 99.48 | 51.65 | 55.71 | 31.98 | 40.84 | 32.36 | 30.17 | 36.11 | Upgrade
|
Other Long-Term Liabilities | 28.78 | 21.93 | 22.72 | 18.66 | 13.73 | 10.39 | 9.3 | 5.51 | 4.51 | 8.81 | Upgrade
|
Total Long-Term Liabilities | 648.08 | 118.47 | 122.2 | 70.31 | 69.43 | 42.37 | 50.14 | 37.87 | 34.67 | 44.92 | Upgrade
|
Total Liabilities | 873.49 | 213.33 | 226.01 | 182.51 | 159.44 | 149.2 | 117.34 | 98.48 | 94.63 | 107.51 | Upgrade
|
Total Debt | 623.64 | 102.58 | 104.66 | 67.27 | 66.63 | 50.21 | 47.16 | 37.72 | 41.1 | 43.7 | Upgrade
|
Debt Growth | 507.94% | -1.99% | 55.59% | 0.97% | 32.68% | 6.48% | 25.01% | -8.22% | -5.95% | 35.83% | Upgrade
|
Retained Earnings | 409.27 | 271.72 | 180.34 | 117.77 | 116.37 | 67.49 | 72.64 | 70.86 | 60.32 | 63.11 | Upgrade
|
Comprehensive Income | -8.48 | -8.62 | -6.77 | -3.72 | -4.69 | -4.01 | -2.1 | -4.7 | -2.48 | -1.65 | Upgrade
|
Shareholders' Equity | 639.42 | 528.66 | 445.52 | 402.31 | 381.37 | 332.44 | 333.74 | 329.26 | 295.51 | 281.86 | Upgrade
|
Net Cash / Debt | -364.4 | 75.62 | 34.45 | 42.41 | 22.89 | 43.11 | 25.23 | 36.55 | 26.26 | 25.62 | Upgrade
|
Net Cash / Debt Growth | - | 119.52% | -18.79% | 85.29% | -46.90% | 70.88% | -30.97% | 39.18% | 2.49% | 12.68% | Upgrade
|
Net Cash Per Share | -6.88 | 1.44 | 0.69 | 0.86 | 0.46 | 0.93 | 0.52 | 0.77 | 0.58 | 0.61 | Upgrade
|
Working Capital | 264.19 | 283.46 | 214.31 | 167.48 | 165.23 | 113.51 | 120.59 | 123.48 | 115.98 | 135.4 | Upgrade
|
Book Value Per Share | 13.25 | 10.89 | 9.32 | 8.55 | 8.12 | 7.17 | 7.24 | 7.26 | 6.57 | 6.72 | Upgrade
|